HCA Healthcare, Inc. (NYSE:HCA) Receives Consensus Recommendation of “Buy” from Analysts

Shares of HCA Healthcare, Inc. (NYSE:HCAGet Rating) have earned an average rating of “Buy” from the twenty-six brokerages that are presently covering the company, Marketbeat Ratings reports. Six investment analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 12-month target price among brokerages that have updated their coverage on the stock in the last year is $258.90.

Several research analysts have weighed in on the stock. UBS Group lowered their target price on shares of HCA Healthcare from $289.00 to $241.00 and set a “buy” rating for the company in a research note on Tuesday, April 26th. Citigroup lowered their price objective on shares of HCA Healthcare from $277.00 to $254.00 and set a “buy” rating for the company in a research note on Monday, April 25th. SVB Leerink lowered their price objective on shares of HCA Healthcare from $304.00 to $273.00 and set an “outperform” rating for the company in a research note on Monday, April 25th. Mizuho lowered their price objective on shares of HCA Healthcare from $290.00 to $260.00 in a research note on Tuesday. Finally, Royal Bank of Canada lowered their price objective on shares of HCA Healthcare from $291.00 to $267.00 and set an “outperform” rating for the company in a research note on Monday, April 25th.

In other HCA Healthcare news, major shareholder Thomas F. Frist, Jr. purchased 89,100 shares of HCA Healthcare stock in a transaction that occurred on Monday, May 2nd. The stock was purchased at an average price of $211.93 per share, for a total transaction of $18,882,963.00. Following the transaction, the insider now directly owns 478,955 shares in the company, valued at $101,504,933.15. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Andrea B. Smith acquired 1,160 shares of the company’s stock in a transaction on Thursday, April 28th. The stock was purchased at an average cost of $213.63 per share, for a total transaction of $247,810.80. Following the completion of the purchase, the director now directly owns 2,239 shares in the company, valued at approximately $478,317.57. The disclosure for this purchase can be found here. In the last quarter, insiders purchased 91,370 shares of company stock valued at $19,373,375 and sold 32,655 shares valued at $8,241,766. 1.50% of the stock is owned by corporate insiders.

Several large investors have recently bought and sold shares of the company. BlackRock Inc. grew its stake in shares of HCA Healthcare by 1.9% during the 4th quarter. BlackRock Inc. now owns 16,377,032 shares of the company’s stock worth $4,207,588,000 after purchasing an additional 313,091 shares during the period. Sanders Capital LLC grew its stake in shares of HCA Healthcare by 16.9% during the 4th quarter. Sanders Capital LLC now owns 9,448,037 shares of the company’s stock worth $2,650,774,000 after purchasing an additional 1,365,582 shares during the period. Geode Capital Management LLC grew its stake in shares of HCA Healthcare by 0.3% during the 4th quarter. Geode Capital Management LLC now owns 3,793,750 shares of the company’s stock worth $971,719,000 after purchasing an additional 10,724 shares during the period. Norges Bank acquired a new position in shares of HCA Healthcare during the 4th quarter worth $596,396,000. Finally, Arrowstreet Capital Limited Partnership boosted its position in shares of HCA Healthcare by 1.8% in the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,292,237 shares of the company’s stock worth $556,372,000 after buying an additional 39,947 shares in the last quarter. 67.87% of the stock is currently owned by institutional investors and hedge funds.

Shares of HCA opened at $224.19 on Friday. The company has a current ratio of 1.43, a quick ratio of 1.24 and a debt-to-equity ratio of 87.46. HCA Healthcare has a 12-month low of $199.76 and a 12-month high of $279.02. The firm has a 50-day moving average price of $251.15 and a 200 day moving average price of $247.24. The firm has a market capitalization of $67.71 billion, a P/E ratio of 10.55, a P/E/G ratio of 1.30 and a beta of 1.61.

HCA Healthcare (NYSE:HCAGet Rating) last announced its earnings results on Friday, April 22nd. The company reported $4.12 earnings per share for the quarter, missing the consensus estimate of $4.25 by ($0.13). The company had revenue of $14.95 billion for the quarter, compared to analysts’ expectations of $14.72 billion. HCA Healthcare had a return on equity of 405.72% and a net margin of 11.40%. The company’s quarterly revenue was up 6.9% compared to the same quarter last year. During the same period last year, the business earned $4.14 EPS. Equities research analysts predict that HCA Healthcare will post 17.15 earnings per share for the current fiscal year.

HCA Healthcare announced that its board has approved a stock repurchase plan on Thursday, January 27th that allows the company to repurchase $8.00 billion in shares. This repurchase authorization allows the company to reacquire up to 10.9% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board of directors believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 30th. Shareholders of record on Thursday, June 16th will be issued a dividend of $0.56 per share. The ex-dividend date is Wednesday, June 15th. This represents a $2.24 dividend on an annualized basis and a yield of 1.00%. HCA Healthcare’s payout ratio is currently 10.54%.

HCA Healthcare Company Profile (Get Rating)

HCA Healthcare, Inc, through its subsidiaries, provides health care services company in the United States. The company operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Further Reading

Analyst Recommendations for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.